Printer Friendly

ELAN ADMITTED TO OFFICIAL LIST ON LONDON AND DUBLIN EXCHANGES

 ATHLONE, Ireland, Nov. 12 /PRNewswire/ -- Elan Corporation, plc (AMEX: ELN) today announced that it has made application to the International Stock Exchange for its entire issued ordinary share capital, currently dealt in on the Unlisted Security Market, to be admitted to the Official List in Dublin and London. It is expected that the admission to the Official List will become effective and that dealing will commence on Thursday, Nov. 18, 1993.
 Donald E. Panoz, chairman and chief executive officer of Elan, commented: "I am pleased that our shares will be admitted to listing in London and Dublin and believe that such listing will facilitate our shareholders, particularly in Europe."
 Elan Corporation, plc is a leading worldwide drug delivery company. Its innovative drug absorption technologies are designed to improve patient care in a cost effective manner. Elan has its principal manufacturing, research and clinical facilities at Athlone, Ireland and other facilities in Gainesville, Ga.; Brea, Calif.; Boston, Mass.; Lincoln, R.I.; Manila, Philippines; Enschede, Holland; and Mezzovico, Switzerland.
 -0- 11/12/93
 /CONTACT: Thomas G. Lynch, executive vice president & CFO, in Ireland, 011-353-902-94666, or Brian Crotty, vice president - communications, 1-800-252-3526, both of Elan/
 (ELN)


CO: Elan Corporation, plc ST: IN: MTC SU:

GK -- NY009 -- 3491 11/12/93 07:21 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 12, 1993
Words:210
Previous Article:CARMEL CONTAINER SYSTEMS, LTD. REPORTS RESULTS FOR THE QUARTER ENDING SEPT. 30, 1993
Next Article:CF INCOME PARTNERS L.P. ANNOUNCES TERMINATION OF DISCUSSIONS WITH AMERICAN CONTINENTAL PROPERTIES
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters